Futura Medical plc
FUM.L · LSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | £0 | £0 | £0 | £0 |
| % Growth | 349.1% | – | – | – |
| Cost of Goods Sold | £0 | £0 | £0 | £0 |
| Gross Profit | £0 | £0 | -£0 | -£0 |
| % Margin | 68.7% | 57.2% | – | – |
| R&D Expenses | £0 | £0 | £0 | £0 |
| G&A Expenses | £0 | £0 | £0 | £0 |
| SG&A Expenses | £0 | £0 | £0 | £0 |
| Sales & Mktg Exp. | £0 | £0 | £0 | £0 |
| Other Operating Expenses | £0 | £0 | £0 | £0 |
| Operating Expenses | £0 | £0 | £0 | £0 |
| Operating Income | £0 | -£0 | -£0 | -£0 |
| % Margin | 8.4% | -224.6% | – | – |
| Other Income/Exp. Net | £0 | £0 | £0 | £0 |
| Pre-Tax Income | £0 | -£0 | -£0 | -£0 |
| Tax Expense | -£0 | -£0 | -£0 | -£0 |
| Net Income | £0 | -£0 | -£0 | -£0 |
| % Margin | 9.3% | -210% | – | – |
| EPS | 0.004 | -0.022 | -0.02 | -0.018 |
| % Growth | 119.9% | -6.4% | -10.9% | – |
| EPS Diluted | 0.004 | -0.022 | -0.02 | -0.018 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | £0 | £0 | £0 | £0 |
| Interest Expense | £0 | £0 | £0 | £0 |
| Depreciation & Amortization | £0 | £0 | £0 | £0 |
| EBITDA | £0 | -£0 | -£0 | -£0 |
| % Margin | 10.1% | -220.4% | – | – |